Get started
Author

Ivan Mlinarić

ORCID: 0009-0008-8546-6331
Observed ORCID: 0009-0008-8546-6331
OpenAlex ID: A5003565656
Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024
2024 · Marine Maurel, Jennifer Howard, et al. · Eurosurveillance · 51
PDF
Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study
2024 · Marine Maurel, Francisco Pozo, et al. · Influenza and Other Respiratory Viruses · 34
PDF
Continued circulation of mpox: an epidemiological and phylogenetic assessment, European Region, 2023 to 2024
2024 · Aisling M Vaughan, Mohammed Afzal, et al. · Eurosurveillance · 30
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021
2022 · Esther Kissling, Mariëtte Hooiveld, et al. · Eurosurveillance · 25
PDF
Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023–January 2024
2024 · Charlotte Laniece Delaunay, Aryse Melo, et al. · Vaccine · 22
Influenza vaccine effectiveness in Europe and the birth cohort effect against influenza A(H1N1)pdm09: VEBIS primary care multicentre study, 2023/24
2025 · Esther Kissling, Marine Maurel, et al. · Eurosurveillance · 18
PDF
COVID‐19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS‐CoV‐2 Infection Among Target Groups in Europe, October 2024–January 2025, VEBIS Primary Care Network
2025 · Charlotte Laniece Delaunay, Nuno Verdasca, et al. · Influenza and Other Respiratory Viruses · 13
PDF
Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS‐CoV‐2 Infection in Older Adults During the JN.1 Lineage‐Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024
2024 · Lore Merdrignac, Charlotte Laniece Delaunay, et al. · Influenza and Other Respiratory Viruses · 12
PDF
The potential bias introduced into COVID-19 vaccine effectiveness studies at primary care level due to the availability of SARS-CoV-2 tests in the general population
2025 · Charlotte Lanièce Delaunay, Baltazar Nunes, et al. · International Journal of Epidemiology · 11
PDF
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans
2024 · Charlotte Laniece Delaunay, Clara Mazagatos, et al. · JAMA Network Open · 9
Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022–23 VEBIS multicentre study in Europe
2024 · Marine Maurel, Clara Mazagatos, et al. · Vaccine · 6
Vaccine effectiveness against influenza A in older adults and the effect of chronic conditions: results from the I-MOVE and VEBIS multicentre European hospital case–control studies, 2015/16–2023/24
2025 · Angela Mary Catherine Rose, Nathalie Nicolay, et al. · BMC Medicine · 5
PDF
Insights into recurring multi-country outbreaks of Salmonella Strathcona associated with tomatoes, Europe, 2011 to 2024
2025 · Vivien Brait, Lena Böff, et al. · Eurosurveillance · 4
PDF
Influenza Vaccine Effectiveness in European Primary Care Pediatric Practices: 2022–2024
2026 · Héloïse Lucaccioni, Marine Maurel, et al. · PEDIATRICS · 3
PDF
Vaccine effectiveness against medically attended, laboratory-confirmed influenza in the I-MOVE primary care network in Europe, VEBIS project, 2024/25
2026 · Héloïse Lucaccioni, Francisco Pozo, et al. · Expert Review of Vaccines · 3
PDF
Emerging Trends in Toxoplasmosis Seroepidemiology in Childbearing-Aged Women in Croatia, 2015–2024
2025 · Mario Sviben, Klara Barbić, et al. · Pathogens · 3
PDF
COVID-19 Vaccine Effectiveness Among Older Adults
2026 · Charlotte Laniece Delaunay, Alberto Mateo-Urdiales, et al. · JAMA Network Open · 2
Identification of the causal odds ratio in test-negative-design studies of COVID-19 vaccine effectiveness
2026 · Charlotte Lanièce Delaunay, Baltazar Nunes, et al. · International Journal of Epidemiology · 1
Vaccine effectiveness against medically attended, laboratory-confirmed influenza in the I-MOVE primary care network in Europe, VEBIS project, 2024/25
2026 · Héloïse Lucaccioni, Francisco Pozo, et al. · Figshare
Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study
2025 · Esther Kissling, Baltazar Nunes, et al. · American Journal of Epidemiology
130 godina Hrvatskog zavoda za javno zdravstvo (1893–2023)
2024 · Ivan Mlinarić · Studia lexicographica
PDF
Corrigendum to “Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: results from the VEBIS primary care test-negative design study, September 2023–January 2024” [Vaccine 42(19) (2024)]
2024 · Charlotte Laniece Delaunay, Aryse Melo, et al. · Vaccine
Author response for "Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study"
2023 · Marine Maurel, Francisco Pozo, et al. · Publons reviews and discussion
Works count: 23
Citation count: 252
H-index: 9
I10-index: 9
Year
Topic
Type